Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-05-15

Clinical Trial Update: Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial update (Phase 2/3) evaluating whether probiotics can prevent spontaneous bacterial peritonitis in patients with liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotics

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Spontaneous Bacterial Peritonitis, Liver Cirrhosis | Phase 2, Phase 3 | Status: UNKNOWN